Vanberra Signal

EquiSeq

Curated by Signal

Genetic tests for horses

Overview

EquiSeq provides genetic tests for horses. The company provides DNA tests for better breeding of horses and to breed out undesirable traits. They are developing new genetic tests for conditions common in some breeds, like Polysaccharide Storage Myopathy type 2 (PSSM2), Recurrent Exertional Rhabdomyolysis (RER), and Myofibrillar Myopathy (MFM). The company has developed tests for three genetic variants that predispose a horse to Polysaccharide Storage Myopathy type 2 (PSSM2) or Myofibrillar Myopathy (MFM), a subtype of PSSM2. These are for horses at risk for developing PSSM2 or MFM before the appearance of symptoms.

Key facts

Founded
2015

Business model

Contact

More on Vanberra Signal

Members only

Competitors & similar companies

More Life Sciences Technology companies
  • Developer of wearable knee rehabilitation device

    Life Sciences TechnologyDallas, United States
  • Neurological monitoring solutions

    Life Sciences TechnologyAmbler, United States
  • Provider of molecular analysis of exhaled breath for diagnostic testing solutions

    Life Sciences TechnologyUnited States

About EquiSeq

What does EquiSeq do?

EquiSeq provides genetic tests for horses.

Where is EquiSeq headquartered?

EquiSeq is headquartered in Albuquerque, United States.

When was EquiSeq founded?

EquiSeq was founded in 2015.

Which sector is EquiSeq in?

EquiSeq operates in Life Sciences Technology.

Who are EquiSeq's competitors?

Companies similar to EquiSeq include Articulate Labs, Moberg, and BreathDX.ai.